Financial Sports Medicine Top Stories Overture Orthopaedics Announces Milestone $1.0M in Sales of its OvertureTi Knee Resurfacing System® to Relieve Pain and Dysfunction Associated with Articular Cartilage Lesions, Osteochondral Defects, and Early Osteoarthritis in the Knee byTim AllenDecember 31, 2025
Sports Medicine Top Stories Overture Orthopaedics Announces Full Commercial Launch of the OvertureTi Knee Resurfacing System® to Treat Early Osteoarthritis and Cartilage Defects byTim AllenJuly 16, 2025
Recon Regulatory Top Stories ReCerf Receives its CE Mark, Advancing Access to Ceramic Hip Resurfacing Across Europe byJosh SandbergJuly 3, 2025
Recon Top Stories JointMedica Announces Launch of IDE Study for Polymotion® Hip Resurfacing System byJosh SandbergApril 1, 2025
Recon Top Stories Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant byChris StewartJanuary 10, 2023
Recon Regulatory Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System byJosh SandbergMay 17, 2022
Recon Top Stories Exactech Announces Shareholding Acquisition of JointMedica, Signaling Return of Hip Resurfacing byJosh SandbergJanuary 24, 2022
Recon The effect of surgical approach on the histology of the femoral head following resurfacing of the hip byJosh SandbergMarch 2, 2015
